Bicarbonate-based solutions for dialysis therapies

Details Bicarbonate-based solutions for dialysis therapies Bicarbonate-based solutions for dialysis therapies

2006-10-17

2006-10-17

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Carbonate

C424S680000, C424S722000

Reexamination Certificate

active

07122210

ABSTRACT:
Bicarbonate containing solutions for use during medical treatment are provided. The bicarbonate containing solution of the present invention includes at least two separate components including a bicarbonate concentrate and an electrolyte concentrate which can be readily and sterilely mixed to form a ready-to-use formulation for patient administration, particularly as applied to the treatment of acute renal failure associated with critically ill patients in an intensive care setting.

REFERENCES:
patent: 3878664 (1975-04-01), Zinke
patent: 4372100 (1983-02-01), Miller et al.
patent: 4396383 (1983-08-01), Hart
patent: 4397392 (1983-08-01), Runck et al.
patent: 4465488 (1984-08-01), Richmond et al.
patent: 4489535 (1984-12-01), Veltman
patent: 4584176 (1986-04-01), Oliver et al.
patent: 4630727 (1986-12-01), Feriani et al.
patent: 4663166 (1987-05-01), Veech
patent: 4756838 (1988-07-01), Veltman
patent: 4761237 (1988-08-01), Alexander et al.
patent: 4863714 (1989-09-01), Sovak et al.
patent: 4879280 (1989-11-01), Seyffart et al.
patent: 4959175 (1990-09-01), Yatzidis
patent: 5011826 (1991-04-01), Steudle et al.
patent: 5039609 (1991-08-01), Klein
patent: 5092838 (1992-03-01), Faict et al.
patent: 5122516 (1992-06-01), Watanabe et al.
patent: 5141492 (1992-08-01), Dadson et al.
patent: 5211643 (1993-05-01), Reinhardt et al.
patent: 5296242 (1994-03-01), Zander
patent: 5383324 (1995-01-01), Segers et al.
patent: 5423421 (1995-06-01), Inoue et al.
patent: 5431496 (1995-07-01), Balteau et al.
patent: 5462526 (1995-10-01), Barney et al.
patent: 5509898 (1996-04-01), Isono et al.
patent: 5536469 (1996-07-01), Jonsson et al.
patent: 5560403 (1996-10-01), Balteau et al.
patent: 5601730 (1997-02-01), Page et al.
patent: 5610170 (1997-03-01), Inoue et al.
patent: 5616248 (1997-04-01), Schal
patent: 5706937 (1998-01-01), Futagawa et al.
patent: 5827820 (1998-10-01), duMoulin et al.
patent: 5853388 (1998-12-01), Semel
patent: 5871477 (1999-02-01), Isono et al.
patent: 5945129 (1999-08-01), Knerr et al.
patent: 6013294 (2000-01-01), Bunke et al.
patent: 6139754 (2000-10-01), Hartranft et al.
patent: 19748290 (1999-05-01), None
patent: 0 083 360 (1983-07-01), None
patent: 0 165 933 (1986-01-01), None
patent: 0 209 607 (1987-01-01), None
patent: 0 249 667 (1987-12-01), None
patent: 0 277 868 (1988-08-01), None
patent: 0 278 100 (1988-08-01), None
patent: 0 399 549 (1990-11-01), None
patent: 0 399 918 (1990-11-01), None
patent: 0 417 478 (1991-03-01), None
patent: 0 437 274 (1991-07-01), None
patent: 0 439 061 (1991-07-01), None
patent: 0 481 257 (1992-04-01), None
patent: 0602014 (1994-06-01), None
patent: 0 613 688 (1994-09-01), None
patent: 0 647 145 (1995-04-01), None
patent: 0 776 649 (1997-06-01), None
patent: 0 935 967 (1999-08-01), None
patent: 1166787 (2002-01-01), None
patent: 2 753 099 (1998-03-01), None
patent: 56164113 (1981-12-01), None
patent: 2304026 (1990-12-01), None
patent: 3195561 (1991-08-01), None
patent: 5105633 (1993-04-01), None
patent: 8131542 (1993-05-01), None
patent: 6105905 (1994-04-01), None
patent: 7252137 (1995-10-01), None
patent: 8164199 (1996-06-01), None
patent: 9087182 (1997-03-01), None
patent: 9110703 (1997-04-01), None
patent: 9301875 (1997-11-01), None
patent: 10201821 (1998-08-01), None
patent: 11-9659 (1999-01-01), None
patent: 11-19178 (1999-01-01), None
patent: 11004872 (1999-01-01), None
patent: WO 86/03407 (1986-06-01), None
patent: WO 87/03809 (1987-07-01), None
patent: WO 91/18610 (1991-12-01), None
patent: WO 95/19778 (1995-07-01), None
patent: WO 96/01118 (1996-01-01), None
patent: WO 97/05851 (1997-02-01), None
patent: WO 98/10733 (1998-03-01), None
patent: WO 99/01144 (1999-01-01), None
patent: WO 99/09953 (1999-03-01), None
patent: WO 01/17534 (2001-03-01), None
van Bommel et al.,Continuous Renal Replacement Therapy for Critically III Patients: An Update, Journal of Intensive Care Medicine, vol. 9, No. 6, Nov.-Dec. 1994, pp. 265-280.
S. Uthoff et al.,Improved Correction of Acidosis in Acute Renal Failure Using a Bicarbonate Buffered Substitution Solution, Nephrology (1997), Suppl. 1, p. 1598.
A. N. Thomas et al,Comparison of lactate and bicarbonate buffered haemofiltration fluids: use in critically ill patients, Nephrology Dialysis Transplantation, (1997), vol. 12, pp. 1212-1217.
Manns et al.,Continuous Renal Replacement Therapies: An Update, American Journal of Kidney Diseases, vol. 32, No. 2 (Aug.) 1998; pp. 185-207.
Feriani et al.,Acid-base balance and replacement solutions in continuous renal replacement therapies, Kidney International, vol. 53, Suppl. 66 (1998), pp. S-156-S-159.
Heering et al.,The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure, Intensive Care Medical (1999) vol. 25, pp. 1244-1251.
Zimmerman et al.,Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution, Nephrology Dialysis Transplantation, (1999) vol. 14, pp. 2387-2391.
Heering et al.,Acid-base balance and substitution fluid during continuous hemofiltration, Kidney International, vol. 56, Suppl. 72 (1999) pp. S-37-S-40.
Lutkes et al.,Continuous venovenous hemodialysis treatment in critically ill patients after liver transplantation, Kidney International, vol. 56 Suppl. 72 (1999) pp. S-71-S-74.
Kierdorf et al.,Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies, Kidney International, vol. 56, Suppl. 72 (1999) pp. S-32-S-36.
Barenbrock et al.,Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients, Kidney International, vol. 58 (2000) pp. 1751-1757.
Manahan et al.,Peritoneal Dialysis using bicarbonate-containing solution sterilized by ultrafiltration, The International Journal of Artificial Organs, vol. 14 No. 8, 1999, pp. 463-465.
Murphy et al.,Use of an Artificial Kidney, vol. 40, 1952, pp. 436-444.
Tjiang, Boen San,A Clinical Study of Factors Governing its Effectiveness, Peritoneal Dialysis, p. 76, Van Gorcum & Co., Assen, The Neterlands (1959).
Feriani et al.,Short-Term Clinical Study with Bicarbonate-Containing Peritoneal Dialysis Solution, Peritoneal Dialysis International, vol. 13, pp. 296-301 (1993).
The Merck Index, 12thEd., Merck Research Laboratories, Whitehouse Station, NJ, 9 1472 (1996).
Odel et al.,Peritoneal Lavage as an Effective Means of Extraenal Excretion. A Clinical Appraisal, American Journal of Medicine, vol. 9, 63-88 (1950).
Schambye et al.,The Cytotoxicity of Continuous Ambulatory Peritoneal Dialysis Solutions with Different Bicarbonate/Lactate Ratios, Peritoneal Dialysis International vol. 13, Suppl. 2, Oct. 1-4, pp. S116-S118 (1994).
Schambye et al.,Bicarbonate-versus Lactate-Based CAPD fluids: A Biocompatibility Study in Rabbits, Peritoneal Dialysis International, vol. 12, pp. 281-286 (1992).
Simonsen et al.,Less Infusion Pain and Elevated Level of Cancer Antigen 125 by the Use of a New and More Biocompatible PD Fluid, Advances in Peritoneal Dialysis, vol. 12, pp. 156-160 (1996).
Ing., et al.,Bicarbonate-Buffered Peritoneal Dialysis, The International Journal of Artificial Organ, vol. 8, No. 3, p. 121-124 (1985).
Zhou et al.,Effects of an Acidic, Lactate-Based Peritoneal Dialysis Solution and its Euhydric, Bicarbonate-Based Counterpart on Neutrophilic Interacellular pH, Int. J. Artif. Organs, vol. 16, No. 12, pp. 816-819 (1993).
American Society for Artificial Internal Organs, 1994 Abstracts, pp. 110.
Faller et al.,Loss of Ultrafiltration in Continuous Ambulatory Peritoneal Dialysis: A Role for Acetate, Peritoneal Dialysis Bulletin, Jan.-Mar. 1984, pp. 10-13.
Ing et al.,Lactate-Containing Peritoneal Dialysis Solutions, International J. of Artificial Organs, vol. 16, No. 10, 1993, pp. 688-693.
Ing et al.,Lactate-Containing Versus Bicarbonate-Containing Peritoneal Dialysis Solutions, Peritoneal Dialysis International, vol. 12, pp. 276-277.
Ing et al.,Preparation of Bicarbonate-Containing Dialysate for Peritoneal Dialysis, International J. of Artificial Organs, vol. 6, No. 4, 1983, pp. 217-218.

Affiliated with

Also associated with

Rating

Bicarbonate-based solutions for dialysis therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicarbonate-based solutions for dialysis therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicarbonate-based solutions for dialysis therapies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3713400